methiothepin has been researched along with Adrenal Cortex Cancer in 1 studies
Methiothepin: A serotonin receptor antagonist in the CENTRAL NERVOUS SYSTEM used as an antipsychotic.
methiothepin : A dibenzothiepine that is 10,11-dihydrodibenzo[b,f]thiepine bearing additional methylthio and 4-methylpiperazin-1-yl substituents at positions 8 and 10 respectively. Potent 5-HT2 antagonist, also active as 5-HT1 antagonist. Differentiates 5-HT1D sub-types. Also displays affinity for rodent 5-HT5B, 5-HT5A, 5-HT7 and 5-HT6 receptors (pK1 values are 6.6, 7.0, 8.4 and 8.7 respectively).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hasanovic, A | 1 |
Ruggiero, C | 1 |
Jung, S | 1 |
Rapa, I | 1 |
Signetti, L | 1 |
Ben Hadj, M | 1 |
Terzolo, M | 1 |
Beuschlein, F | 1 |
Volante, M | 1 |
Hantel, C | 1 |
Lalli, E | 1 |
Mus-Veteau, I | 1 |
1 other study available for methiothepin and Adrenal Cortex Cancer
Article | Year |
---|---|
Targeting the multidrug transporter Patched potentiates chemotherapy efficiency on adrenocortical carcinoma in vitro and in vivo.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Animals; Cell Line, Tumor; Cell Proliferation; C | 2018 |